Nektar Therapeutics | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
162,013.00
53,916.00
81,177.00
153,524.00
96,692.00
681,313
Depreciation, Depletion & Amortization
14,275.00
12,927.00
12,855.00
15,351.00
14,741.00
10,870
Other Funds
18,626.00
15,408.00
29,944.00
13,219.00
39,153.00
65,037
Funds from Operations
129,112.00
25,581.00
38,378.00
124,954.00
42,798.00
757,220
Changes in Working Capital
90,585.00
116,425.00
34,705.00
7,930.00
37,616.00
39,006
Net Operating Cash Flow
38,527.00
142,006.00
73,083.00
117,024.00
80,414.00
718,214
Capital Expenditures
4,091.00
9,976.00
11,195.00
6,392.00
9,676.00
Purchase/Sale of Investments
54,000.00
27,595.00
28,141.00
76,008.00
19,133.00
Net Investing Cash Flow
49,909.00
37,571.00
39,336.00
82,400.00
28,809.00
Issuance/Reduction of Debt, Net
5,992.00
10,536.00
98,575.00
5,945.00
5,131.00
Net Financing Cash Flow
2,216.00
152,984.00
130,783.00
203,618.00
54,391.00
Net Change in Cash
13,630.00
26,702.00
18,205.00
4,070.00
54,878.00
Free Cash Flow
42,618.00
151,982.00
84,278.00
123,416.00
90,090.00
Change in Capital Stock
8,208.00
163,520.00
32,208.00
209,563.00
59,522.00
Exchange Rate Effect
32.00
109.00
159.00
124.00
46.00
About Nektar Therapeutics
View Profile
